Online Only Articles

The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies

Princess Margaret Cancer Centre, Toronto, ON, Canada
Guy’s and St Thomas’ NHS Foundation, London, UK
University of Pennsylvania, Philadelphia, PA, USA
University Hospital of Leipzig, Germany
St. Paul’s Hospital, University of British Columbia, Vancouver, BC, Canada
Incyte Corporation, Wilmington, DE, USA
Incyte Corporation, Wilmington, DE, USA
Novartis Pharma AG, Basel, Switzerland
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Vol. 101 No. 12 (2016): December, 2016 https://doi.org/10.3324/haematol.2016.151449